Status:
COMPLETED
Impact of Uterotonic Agents on Isolated Human Myometrium
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The purpose of this study is to compare the ability of a sample of uterine muscle tissue to contract in the presence of various drugs. The drugs studied are typically used to contract the uterus when ...
Detailed Description
Postpartum hemorrhage (PPH) is a major cause of maternal mortality and morbidity. In 80% cases of PPH, the primary cause is failure of the uterus to contract after delivery of the baby, which then req...
Eligibility Criteria
Inclusion
- Gestational age 37-41 weeks
- Non-laboring patients, not exposed to exogenous oxytocin
- Patients requiring primary Cesarean section
- Cesarean section under spinal anesthesia
Exclusion
- Patients who require general anesthesia
- Patient who had previous uterine surgery or Cesarean section
- Patients with placental anomalies
- Emergency Cesarean section in labor
- Patients with bleeding disorders
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00989027
Start Date
June 1 2007
End Date
August 1 2013
Last Update
February 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5